Clinical Trial

Registry of Myelodysplastic Syndromes and Therapy-related Acute Myeloid Leukemia

Recruiting
View on ClinicalTrials.gov →
Summary
The Registry MDS is an ongoing, observational study that has collected longitudinal data on diagnostics, demographics, clinical parameters, and health Care Interventions (HCI) from patients with MDS and therapy-related acute myeloid leukemia
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-05-01.
Trial Details
NCT Number NCT06956755
Lead Sponsor Groupe Francophone des Myelodysplasies
Conditions Myelodysplastic Syndromes, Leukemia, Myeloid, Acute
Enrollment 6,990 participants
Start Date 2003-07-07
Primary Completion 2030-01-05 (estimated)
Study Completion 2031-01-05 (estimated)
Updated on ClinicalTrials.gov 2025-05-06